LENTARON Trademark
Trademark Overview
On Wednesday, November 29, 2000, a trademark application was filed for LENTARON with the United States Patent and Trademark Office. The USPTO has given the LENTARON trademark a serial number of 78036980. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, February 22, 2002. This trademark is owned by Novartis AG. The LENTARON trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations for the treatment of cancer
General Information
| Serial Number | 78036980 |
| Word Mark | LENTARON |
| Filing Date | Wednesday, November 29, 2000 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Friday, February 22, 2002 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | pharmaceutical preparations for the treatment of cancer |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 6, 2000 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Basel
CH |
Trademark Events
| Event Date | Event Description |
| Friday, February 22, 2002 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, May 7, 2001 | NON-FINAL ACTION MAILED |
| Tuesday, May 1, 2001 | ASSIGNED TO EXAMINER |
